MEDBOX | Toolbox Immunization Guidelines

Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine

World Health Organization WHO (2022) C_WHO

6 June 2022 These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. This document has been updated: Version 6 June 2022

Tags: vaccine, johnson&Johnson, recommendations, approval, COVID-19, SARS-CoV-2, vector-basierter Impfstoff,

Source: https://apps.who.int/iris/rest/bitstream

COVID-19 Exercise Programme - Drills for Vaccine Deployment

WHO (2022) C_WHO

This drill package is part of a broader COVID-19 simulation exercise package, including vaccine tabletop exercises(TTX). For exercises to be most effective, it is recommended they should be part of a comprehensive programme made up of progressively complex exercises, each exercise building on the previous one until they are as close to reality as possible Available in English, Arabic, Chinese, French, Russian, Spanish and Portugues

Tags: COVID-19, exercise programme, vaccine, Health Workers, simulation exercise,

Source: https://www.who.int/docs/default-source/

Vygen-Bonnet S, Koch J, Bogdan C, et al. (2022) C1

Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfempfehlung ist es, Personen, die eine COVID-19-Impfung mit einem der nicht in der EU zugelassenen Ganzvirusimpfstoffen (CoronaVac, Covilo und Covaxin) oder dem Vektor-basierten Impfstoff Sputnik V erhalten haben, mit einem Impfschutz auszustatten, der vergleichbar mit dem einer Grundimmunisierung plus Auffrischimpfung mit einem mRNA-Impfstoff ist

Tags: Impfungen, COVID-19, Strategie, Verteilung, Ethik, Risikogruppen, Priorisierung, Deutschland, mRNA, vector-basierter Impfstoff, Astra Zeneca, Moderna, pfizer, Risiko, Sinusvenenthrombosen, Zweitimpfung, johnson&Johnson, pediatrics, Children, Adolescents, booster,

Source: https://www.rki.de/DE/Content/Infekt/Epi

Injection safety in the context of coronavirus disease (COVID-19) vaccination

Infection Prevention and Control UHL, WHO Headquarters (2022) C_WHO

5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and broad short-term and long-term solutions to address and alleviate supply shortages related to vaccine products with non-standard dose volumes

Tags: Guidance brief, injection safety, COVID-19,

Source: https://apps.who.int/iris/rest/bitstream

Vaccine Safety Basics

Open WHO; World Health Organization WHO (2022) C_WHO

This course introduces participants to the foundations of vaccine pharmacovigilance. The aim of this course is to provide healthcare professionals whose work involve vaccine safety issues, with essential knowledge about vaccines and their safety aspects. These professionals can include nurses, midwives, community health workers, as well as pharmacists, medical doctors and immunization programme or vaccine safety communication officers

Tags: vaccine, safety, pharmacovigilance, Online Courses, healthworkers, Community Health Worker (CHW), midwives,

Source: https://openwho.org/courses/vaccine-safe

Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19

World Health Organization WHO (2022) C_WHO

23 Februrary 2022. interim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022 These WHO interim recommendations on the use of the mRNA-1273 vaccine (Moderna) against COVID-19b2 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below

Tags: Moderna, vaccine, COVID-19, mRNA,

Source: https://apps.who.int/iris/bitstream/hand

World Health Organization WHO (2022) C_WHO

Tags: Pregnancy, COVID-19, Vaccination,

Source: https://apps.who.int/iris/bitstream/hand

Organisation Mondiale de la Santé OMS (2022) C_WHO

orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022

Tags: Vaccination, COVID-19, SARS-CoV-2, mRNA, strategy, recommendations,

Source: https://apps.who.int/iris/bitstream/hand

Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing

World Health Organization WHO (2022) C_WHO

These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. This document has been updated: Version 21 January 2022. Available in Arabic, Chinese, English, French, Russian and Spanish here:https://apps.who.int/iris/handle/10665/34930

Tags: Vaccination, COVID-19, SARS-CoV-2, mRNA, strategy, recommendations, biontech, pfizer, Comirnaty,

Source: https://apps.who.int/iris/rest/bitstream

Episode #71 - COVID-19 vaccines and children

World Health Organization WHO (2022) C_WHO

11 May 2022 What are WHO's recommendations for COVID-19 vaccines and children? And what does the evidence say so far about the safety of these vaccines in children? And if you live in a country where this vaccination is not available for your kids, how can you keep them safe? WHO’s Dr Soumya Swaminathan explains in Science in 5

Tags: Vaccination, COVID-19, Children, Video,

Source: https://youtu.be/hmIK-nZ3ukA

	Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine World Health Organization WHO (2022) C_WHO View PDF(24) Download (20) Add to my MEDBOX 6 June 2022 These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. This document has been updated: Version 6 June 2022 Tags: vaccine, johnson&Johnson, recommendations, approval, COVID-19, SARS-CoV-2, vector-basierter Impfstoff, Source: https://apps.who.int/iris/rest/bitstream
	COVID-19 Exercise Programme - Drills for Vaccine Deployment WHO (2022) C_WHO Open external link (107) Add to my MEDBOX This drill package is part of a broader COVID-19 simulation exercise package, including vaccine tabletop exercises(TTX). For exercises to be most effective, it is recommended they should be part of a comprehensive programme made up of progressively complex exercises, each exercise building on the previous one until they are as close to reality as possible Available in English, Arabic, Chinese, French, Russian, Spanish and Portugues Tags: COVID-19, exercise programme, vaccine, Health Workers, simulation exercise, Source: https://www.who.int/docs/default-source/
	Beschluss der STIKO zur 19. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung Vygen-Bonnet S, Koch J, Bogdan C, et al. (2022) C1 View PDF(73) Download (60) Add to my MEDBOX Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfempfehlung ist es, Personen, die eine COVID-19-Impfung mit einem der nicht in der EU zugelassenen Ganzvirusimpfstoffen (CoronaVac, Covilo und Covaxin) oder dem Vektor-basierten Impfstoff Sputnik V erhalten haben, mit einem Impfschutz auszustatten, der vergleichbar mit dem einer Grundimmunisierung plus Auffrischimpfung mit einem mRNA-Impfstoff ist Tags: Impfungen, COVID-19, Strategie, Verteilung, Ethik, Risikogruppen, Priorisierung, Deutschland, mRNA, vector-basierter Impfstoff, Astra Zeneca, Moderna, pfizer, Risiko, Sinusvenenthrombosen, Zweitimpfung, johnson&Johnson, pediatrics, Children, Adolescents, booster, Source: https://www.rki.de/DE/Content/Infekt/Epi
	Injection safety in the context of coronavirus disease (COVID-19) vaccination Infection Prevention and Control UHL, WHO Headquarters (2022) C_WHO View PDF(16) Download (17) Add to my MEDBOX 5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and broad short-term and long-term solutions to address and alleviate supply shortages related to vaccine products with non-standard dose volumes Tags: Guidance brief, injection safety, COVID-19, Source: https://apps.who.int/iris/rest/bitstream
	Vaccine Safety Basics Open WHO; World Health Organization WHO (2022) C_WHO Open external link (112) Add to my MEDBOX This course introduces participants to the foundations of vaccine pharmacovigilance. The aim of this course is to provide healthcare professionals whose work involve vaccine safety issues, with essential knowledge about vaccines and their safety aspects. These professionals can include nurses, midwives, community health workers, as well as pharmacists, medical doctors and immunization programme or vaccine safety communication officers Tags: vaccine, safety, pharmacovigilance, Online Courses, healthworkers, Community Health Worker (CHW), midwives, Source: https://openwho.org/courses/vaccine-safe
	Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 World Health Organization WHO (2022) C_WHO View PDF(23) Download (25) Add to my MEDBOX 23 Februrary 2022. interim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022 These WHO interim recommendations on the use of the mRNA-1273 vaccine (Moderna) against COVID-19b2 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below Tags: Moderna, vaccine, COVID-19, mRNA, Source: https://apps.who.int/iris/bitstream/hand
	Questions and answers: COVID-19 vaccines and pregnancy, 15 February 2022 World Health Organization WHO (2022) C_WHO View PDF(11) Download (12) Add to my MEDBOX Tags: Pregnancy, COVID-19, Vaccination, Source: https://apps.who.int/iris/bitstream/hand
	Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 Pfizer-BioNTech, BNT162b2, en vertu du protocole OMS d’autorisation d’utilisation d’urgence Organisation Mondiale de la Santé OMS (2022) C_WHO View PDF(14) Download (12) Add to my MEDBOX orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022 Tags: Vaccination, COVID-19, SARS-CoV-2, mRNA, strategy, recommendations, Source: https://apps.who.int/iris/bitstream/hand
	Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing World Health Organization WHO (2022) C_WHO View PDF(26) Download (26) Add to my MEDBOX These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. This document has been updated: Version 21 January 2022. Available in Arabic, Chinese, English, French, Russian and Spanish here:https://apps.who.int/iris/handle/10665/34930 Tags: Vaccination, COVID-19, SARS-CoV-2, mRNA, strategy, recommendations, biontech, pfizer, Comirnaty, Source: https://apps.who.int/iris/rest/bitstream
	Episode #71 - COVID-19 vaccines and children World Health Organization WHO (2022) C_WHO Open external link (43) Add to my MEDBOX 11 May 2022 What are WHO's recommendations for COVID-19 vaccines and children? And what does the evidence say so far about the safety of these vaccines in children? And if you live in a country where this vaccination is not available for your kids, how can you keep them safe? WHO’s Dr Soumya Swaminathan explains in Science in 5 Tags: Vaccination, COVID-19, Children, Video, Source: https://youtu.be/hmIK-nZ3ukA

About MEDBOX

MEDBOX Video Series